• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估组织学分级和组织学无肿瘤切缘作为完全切除的犬肥大细胞瘤局部复发预测指标的研究。

Evaluation of histological grade and histologically tumour-free margins as predictors of local recurrence in completely excised canine mast cell tumours.

作者信息

Donnelly L, Mullin C, Balko J, Goldschmidt M, Krick E, Hume C, Brown D C, Sorenmo K

机构信息

School of Veterinary Medicine, Matthew J. Ryan Veterinary Hospital, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Vet Comp Oncol. 2015 Mar;13(1):70-6. doi: 10.1111/vco.12021. Epub 2013 Mar 4.

DOI:10.1111/vco.12021
PMID:23451809
Abstract

Completeness of mast cell tumour (MCT) excision is determined by assessment of histologically tumour-free margins (HTFM). The HTFM width necessary to prevent local recurrence (LR), recognized as histologic safety margin (HSM) in human oncology, has not been defined. We hypothesized that HTFM width would correlate with risk for LR and high-grade tumours would require wider HTFM than low-grade tumours. Records of dogs with completely excised MCTs were included. Signalment, two-tier tumour grade, tumour size, HTFM width, recurrence and therapy data was collected. High-grade (n = 39) tumours were more likely to recur than low-grade (n = 51) tumours (35.9% versus 3.9%), P < 0.0001, with no association between HTFM width and LR. Twenty-nine percent of low-grade tumours had HTFM less than 3 mm; none recurred. Narrow (≤3 mm) histologic margins are likely adequate to prevent LR of low-grade tumours. High-grade tumours have significant risk of LR regardless of HTFM width.

摘要

肥大细胞瘤(MCT)切除的完整性通过对组织学上无肿瘤切缘(HTFM)的评估来确定。在人类肿瘤学中被视为组织学安全切缘(HSM)的预防局部复发(LR)所需的HTFM宽度尚未明确。我们假设HTFM宽度与LR风险相关,并且高级别肿瘤比低级别肿瘤需要更宽的HTFM。纳入了MCT完全切除的犬只记录。收集了信号、两级肿瘤分级、肿瘤大小、HTFM宽度、复发和治疗数据。高级别(n = 39)肿瘤比低级别(n = 51)肿瘤更易复发(35.9%对3.9%),P < 0.0001,HTFM宽度与LR之间无关联。29%的低级别肿瘤HTFM小于3毫米;无一复发。狭窄(≤3毫米)的组织学切缘可能足以预防低级别肿瘤的LR。无论HTFM宽度如何,高级别肿瘤都有显著的LR风险。

相似文献

1
Evaluation of histological grade and histologically tumour-free margins as predictors of local recurrence in completely excised canine mast cell tumours.评估组织学分级和组织学无肿瘤切缘作为完全切除的犬肥大细胞瘤局部复发预测指标的研究。
Vet Comp Oncol. 2015 Mar;13(1):70-6. doi: 10.1111/vco.12021. Epub 2013 Mar 4.
2
Evaluation of a modified proportional margin approach for complete surgical excision of canine cutaneous mast cell tumours and its association with clinical outcome.评估改良比例边界方法在犬皮肤肥大细胞瘤完全手术切除中的应用及其与临床结果的关系。
Vet Comp Oncol. 2021 Dec;19(4):604-615. doi: 10.1111/vco.12630. Epub 2020 Jul 23.
3
Reductions in margin length after excision of grade II mast cell tumors and grade I and II soft tissue sarcomas in dogs.犬II级肥大细胞瘤以及I级和II级软组织肉瘤切除术后切缘长度的缩短情况。
Vet Surg. 2018 Jan;47(1):36-43. doi: 10.1111/vsu.12731. Epub 2017 Oct 24.
4
Comparison of histologic margin status in low-grade cutaneous and subcutaneous canine mast cell tumours examined by radial and tangential sections.通过径向和切线切片检查的犬低度皮肤和皮下肥大细胞瘤组织学切缘状态的比较。
Vet Comp Oncol. 2018 Mar;16(1):125-130. doi: 10.1111/vco.12321. Epub 2017 May 23.
5
Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994-2002).皮肤II级肥大细胞瘤手术切除不完全后的复发率、临床结局及细胞增殖指数作为预后指标:28只犬(1994 - 2002年)
J Vet Intern Med. 2006 Jul-Aug;20(4):933-40. doi: 10.1892/0891-6640(2006)20[933:rrcoac]2.0.co;2.
6
Long-term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2-year-long study.接受肥大细胞瘤和软组织肉瘤手术切除的犬类的长期预后:一项为期2年的前瞻性研究。
Vet Surg. 2020 Jan;49(1):96-105. doi: 10.1111/vsu.13225. Epub 2019 May 2.
7
Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.对犬 I 级和 II 级皮肤肥大细胞瘤切除时两厘米外侧手术切缘的评估。
J Am Vet Med Assoc. 2006 Jan 15;228(2):210-5. doi: 10.2460/javma.228.2.210.
8
Additional local therapy with primary re-excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs.对于犬肥大细胞瘤不完全或切缘接近的手术切除,采用再次局部切除或放射治疗等额外的局部治疗可提高生存率并改善局部控制情况。
Vet Surg. 2014 Feb;43(2):182-9. doi: 10.1111/j.1532-950X.2014.12099.x. Epub 2014 Jan 6.
9
Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).2004 - 2008年采用手术切除治疗犬耳廓MCTs的临床结果。
J Am Anim Hosp Assoc. 2014 May-Jun;50(3):187-91. doi: 10.5326/JAAHA-MS-6039. Epub 2014 Mar 21.
10
Patient and tumour factors influencing canine mast cell tumour histological grade and mitotic index.影响犬肥大细胞瘤组织学分级和有丝分裂指数的患者和肿瘤因素。
Vet Comp Oncol. 2019 Sep;17(3):338-344. doi: 10.1111/vco.12477. Epub 2019 Apr 25.

引用本文的文献

1
Recurrence and metastasis of cutaneous and subcutaneous tumors following excision with advanced surgical margin assessment.采用先进的手术切缘评估进行切除后皮肤和皮下肿瘤的复发与转移
Can Vet J. 2025 Aug 1;66(8):883-891. eCollection 2025 Aug.
2
Clinical outcomes of dogs with high-grade cutaneous mast cell tumors.患有高级别皮肤肥大细胞瘤的犬只的临床结局
Front Vet Sci. 2025 Jan 21;11:1519636. doi: 10.3389/fvets.2024.1519636. eCollection 2024.
3
Characterisation and Sensitivity of a Canine Mast Cell Tumour Line to Oncolytic Viruses.
犬肥大细胞瘤细胞系对溶瘤病毒的特性及敏感性
Vet Comp Oncol. 2025 Mar;23(1):42-51. doi: 10.1111/vco.13024. Epub 2024 Nov 11.
4
Tumor Grade and Mitotic Count Are Prognostic for Dogs with Cutaneous Mast Cell Tumors Treated with Surgery and Adjuvant or Neoadjuvant Vinblastine Chemotherapy.肿瘤分级和有丝分裂计数对接受手术及辅助或新辅助长春碱化疗的犬皮肤肥大细胞瘤具有预后意义。
Vet Sci. 2024 Aug 10;11(8):363. doi: 10.3390/vetsci11080363.
5
Mitotic activity: A systematic literature review of the assessment methodology and prognostic value in canine tumors.有丝分裂活性:犬肿瘤评估方法学和预后价值的系统文献回顾。
Vet Pathol. 2024 Sep;61(5):752-764. doi: 10.1177/03009858241239565. Epub 2024 Mar 27.
6
Weishaar's classification system for nodal metastasis in sentinel lymph nodes: Clinical outcome in 94 dogs with mast cell tumor.魏沙尔的前哨淋巴结淋巴结转移分类系统:94 例肥大细胞瘤犬的临床转归。
J Vet Intern Med. 2024 May-Jun;38(3):1675-1685. doi: 10.1111/jvim.16997. Epub 2024 Mar 1.
7
Development of a flow cytometric panel to assess prognostic biomarkers in fine needle aspirates of canine cutaneous or subcutaneous mast cell tumors.开发一种流式细胞术检测方法,以评估犬皮肤或皮下肥大细胞瘤细针穿刺抽吸物中的预后生物标志物。
Front Vet Sci. 2023 Nov 21;10:1279881. doi: 10.3389/fvets.2023.1279881. eCollection 2023.
8
Enabling Chemo-Immunotherapy with HIFU in Canine Cancer Patients.利用高强度聚焦超声在犬科癌症患者中实施化疗免疫治疗。
Ann Biomed Eng. 2024 Jul;52(7):1859-1872. doi: 10.1007/s10439-023-03194-1. Epub 2023 May 10.
9
Histology: The gold standard for diagnosis?组织学:诊断的金标准?
Can Vet J. 2023 Apr;64(4):389-391.
10
Scar revision for incompletely or narrowly excised cutaneous mast cell tumors in dogs.犬皮肤肥大细胞瘤不完全或局限性切除后的瘢痕修复。
Can Vet J. 2023 Jan;64(1):63-69.